Zosano Pharma Files IND for a Phase 2/3 Clinical Study in Cluster Headache
Zosano Pharma (NASDAQ:ZSAN) has announced it has filed an investigational new drug application to the US Food and Drug Administration (FDA) for a Phase 2/23 clinical trial of C213 in patients with cluster headaches. As quoted in the press release: C213, for the treatment of cluster headache, consists of the company’s investigational proprietary formulation of …
Zosano Pharma (NASDAQ:ZSAN) has announced it has filed an investigational new drug application to the US Food and Drug Administration (FDA) for a Phase 2/23 clinical trial of C213 in patients with cluster headaches.
As quoted in the press release:
C213, for the treatment of cluster headache, consists of the company’s investigational proprietary formulation of zolmitriptan delivered utilizing its proprietary ADAM technology, which consists of titanium microneedles coated with drug, and is the same formulation as Qtrypta, for the acute treatment of migraine.
“There is a substantial need for new treatment options for people suffering from cluster headache, which produces an excruciating pain that has been described as one of the most severe types of pain known to medical science,” said Don Kellerman, Vice President of Clinical Development and Medical Affairs. “The challenge with treating this debilitating condition is that the attacks are relatively short-lasting and quick onset medications are required in order to provide meaningful benefit to patients. Based on the pharmacokinetic profile and onset of pain relief seen in our clinical trials with Qtrypta for Migraines, we believe C213 has the potential to be a transformational therapy for patients with cluster headaches.”
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1818.46 | -0.35 | |
Silver | 20.59 | -0.15 | |
Copper | 3.71 | -0.07 | |
Palladium | 1883.50 | -78.50 | |
Platinum | 903.50 | -15.50 | |
Oil | 108.29 | -1.49 | |
Heating Oil | 3.91 | -0.04 | |
Natural Gas | 6.54 | +0.04 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.